Entellus: Helping The Interventional Revolution Balloon In Sinus Therapy
Executive Summary
The second company in the US looking to replace certain sinus surgeries with interventional procedures, Entellus is looking to further advance this technology by moving treatment from the OR to the doctor's office.
You may also be interested in...
ENT Devices: Large Markets, Minimally Invasive Procedures Fuel Innovation
For innovators in the medical device industry, the otolaryngology or ENT (ear, nose, and throat) specialty offers just about everything that investors look for these days. Profiles of Aerin Medical, Spirox, Fiagon AG Medical, and ENTvantage Diagnostics.
Companies See Opportunities In Expanding ENT Market
The ear, nose, and throat market now boasts several large device manufacturers that see possibilities in this space for innovative new minimally invasive products. Such competition is the ideal landscape for innovation, as the large companies battle for market share, while start-up firms and VCs see opportunities to take the market in new directions.
Companies See Opportunities In Expanding ENT Market
Competition breeds innovation, and the ear, nose, and throat (ENT) market, once a fairly quiet arena, is now positioned to host some spirited activity that should lead to new technologies. Several large device manufacturers have recently moved into the ENT space, and the sinus treatment segment of the market has become one of the focal points for emerging competitors, as companies work toward less-invasive treatment options.